Application of personalized nursing in acute leukemia patients with central venous catheterization through peripheral venous puncture
Qin Zhang Affiliated Hospital of North Sichuan Medical College, Nanchong Sichuan 637000, China
Abstract:Objective To analyze the effects of personalized nursing intervention protocols on catheter retention duration, disease uncertainty perception, patient comfort levels, and nursing theory-practice training performance in acute leukemia patients undergoing peripherally accessed central venous catheterization (CVC) during care. Methods A total of 50 acute leukemia patients who received CVC procedures at our hospital between December 2023 and November 2024 were selected for observation. Participants were randomly assigned to either a control group receiving standard care or an observation group implementing personalized interventions. Results The observation group demonstrated significantly better catheter retention duration and reduced disease uncertainty perception compared to the control group (P<0.05). Post-treatment, the observation group also showed markedly improved comfort levels (P<0.05). Nursing staff in the observation group achieved superior performance in theoretical knowledge, catheter blockage management, dressing changes, and hemorrhage care compared to control group members (P<0.05). Conclusion Personalized nursing protocols tailored to individual patient needs demonstrate distinct advantages for acute leukemia patients undergoing CVC procedures. These interventions not only prolong catheter retention duration but also enhance nursing quality, thereby promoting better rehabilitation outcomes. Keywords : acute leukemia;personalized nursing;peripherally inserted central venous catheterization;catheter time;comfort
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.